{
    "root": "2e524986-7903-416f-b2b8-d27295103e75",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Doxazosin mesylate",
    "value": "20240311",
    "ingredients": [
        {
            "name": "DOXAZOSIN MESYLATE",
            "code": "86P6PQK0MU",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_4709"
        },
        {
            "name": "LACTOSE, UNSPECIFIED FORM",
            "code": "J2B2A4N98G",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        }
    ],
    "indications": {
        "text": "doxazosin alpha 1 adrenergic antagonist indicated : \u2022 signs symptoms benign prostatic hyperplasia ( bph ) ( 1.1 ) \u2022 treatment hypertension ( 1.2 )",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "\u2022 treatment bph : initiate therapy 1 mg daily . dose may titrated 1 2-week intervals , 8 mg daily . ( 2.2 ) \u2022 treatment hypertension : initiate therapy 1 mg daily . dose may titrated needed , 16 mg daily . ( 2.3 )",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "doxazosin available tablets oral . tablet contains doxazosin mesylate equivalent 1 mg ( white ) , 2 mg ( white ) , 4 mg ( white ) 8 mg ( white ) doxazosin free base . ndc pack size strength description ndc 59762-1388-7 ( bottle 100 ) 1 mg white , round tablets \u201c cn1 \u201d one side \u201c vle \u201d side . ndc 59762-1389-7 ( bottle 100 ) 2 mg white , oblong tablets score \u201c cn 2 \u201d one side \u201c vle \u201d side . ndc 59762-1390-7 ( bottle 100 ) 4 mg white , rhombus shaped tablets break score \u201c cn 4 \u201d one side vle side . ndc 59762-1391-7 ( bottle 100 ) 8 mg white , capsule shaped tablets break score \u201c cn 8 \u201d one side \u201c vle \u201d side . recommended storage : store 25\u00b0c ( 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) [ usp controlled room temperature ] .",
    "adverseReactions": "doxazosin tablet contraindicated patients hypersensitivity doxazosin , quinazolines ( e.g . , prazosin , terazosin ) , components .",
    "indications_original": "Doxazosin is an alpha 1 adrenergic antagonist indicated for: \u2022 Signs and symptoms of Benign Prostatic Hyperplasia (BPH) ( 1.1 ) \u2022 Treatment of Hypertension ( 1.2 )",
    "contraindications_original": "\u2022 For the treatment of BPH: Initiate therapy at 1 mg once daily. Dose may be titrated at 1 to 2-week intervals, up to 8 mg once daily. ( 2.2 ) \u2022 For the treatment of hypertension: Initiate therapy at 1 mg once daily. Dose may be titrated as needed, up to 16 mg once daily. ( 2.3 )",
    "warningsAndPrecautions_original": "Doxazosin is available as tablets for oral administration. Each tablet contains Doxazosin mesylate equivalent to 1\u00a0mg (white), 2\u00a0mg (white), 4\u00a0mg (white) or 8\u00a0mg (white) of doxazosin as the free base.\n                  \n                     \n                     \n                     \n                     \n                        \n                           \n                              NDC and Pack Size\n                           \n                           \n                              Strength\n                           \n                           \n                              Description\n                           \n                        \n                        \n                           \n                              NDC\u00a059762-1388-7 (Bottle of 100)\n                           \n                           \n                              1\u00a0mg\n                           \n                           \n                              White, round tablets with \u201cCN1\u201d on one side and \u201cVLE\u201d on the other side.\n                           \n                        \n                        \n                           \n                              NDC\u00a059762-1389-7 (Bottle of 100)\n                           \n                           \n                              2\u00a0mg\n                           \n                           \n                              White, oblong tablets with score and \u201cCN 2\u201d on one side and \u201cVLE\u201d on the other side.\n                           \n                        \n                        \n                           \n                              NDC\u00a059762-1390-7 (Bottle of 100)\n                           \n                           \n                              4\u00a0mg\n                           \n                           \n                              White, rhombus shaped tablets with break score and \u201cCN 4\u201d on one side and VLE on the other side.\n                           \n                        \n                        \n                           \n                              NDC\u00a059762-1391-7 (Bottle of 100)\n                           \n                           \n                              8\u00a0mg\n                           \n                           \n                              White, capsule shaped tablets with break score and \u201cCN 8\u201d on one side and \u201cVLE\u201d on the other side.\n                           \n                        \n                     \n                  \n                  Recommended Storage: Store at 25\u00b0C (77\u00b0F); excursions permitted from 15\u00b0C to 30\u00b0C (59\u00b0F to 86\u00b0F) [see USP Controlled Room Temperature].",
    "adverseReactions_original": "The use of Doxazosin tablet is contraindicated in patients with a hypersensitivity to doxazosin, other quinazolines (e.g., prazosin, terazosin), or any of its components.",
    "drug": [
        {
            "name": "Doxazosin mesylate",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_4709"
        }
    ]
}